When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.

When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.

Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.

When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.

Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.

What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.

How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.

What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.

When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?

Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?

How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.

What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?

When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?

When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.

What patients in Europe and the UK need to know about vamorolone's availability timeline.

When will Zavegepant be available in the UK (and what to do in the meantime)

Where is Enhertu approved for the treatment of advanced NSCLC, and how can you access it?

How to safely access Ozempic in Australia until the medicine shortage is resolved.

How to safely access Ozempic in the UK until the medicine shortage is resolved.

How effective is Enhertu for colorectal cancer? Find out the latest trial results and what they can mean for your treatment.

Inclisiran could play a role in preventing cardiovascular events. Find out all about its availability in the UK, and what it can mean for you.

Pirtobrutinib is not yet approved and available in the EU and UK. But doesn't mean you can't access it immediately. Read on for all your options.

Belzutifan is currently approved as an orphan medicine in the UK. Find out when it will be widely available on the market, and what that means for you.

Everything you should know about Enhertu in the UK. What is it approved for, and how can you access it?

How effective is Enhertu for ovarian cancer, and can your doctor prescribe it before it's approved for this indication? All the answers - here.

What happens after Adakveo's revocation in the EU? Understand the reasons for the EMA's decision, and the Adakveo alternatives you have.

Find out the key similarities and differences between Adakveo and Oxbryta, including how to access both medicines.

When will dostarlimab be available in Belgium? Find out all the ways to access it in the meantime.

When will dostarlimab be available in the UK? Learn everything worth knowing about accessing the medicine.

Why teclistamab isn't available in Germany (yet) and how to access it in the meantime.